男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

CureVac fails in COVID-19 vaccine trial with 47% efficacy

By Ouyang Xueyan | chinadaily.com.cn | Updated: 2021-06-18 00:04
Share
Share - WeChat

German biotech CureVac's COVID-19 vaccine has come out of a late-stage trial with 47 percent efficacy but the health ministry has said this will not impact the country's vaccination rollout.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板： 龙南县| 遂川县| 香格里拉县| 福州市| 龙里县| 清新县| 武冈市| 吴堡县| 司法| 定安县| 普安县| 偏关县| 滁州市| 双牌县| 九寨沟县| 墨竹工卡县| 大悟县| 盐源县| 昌邑市| 淅川县| 西峡县| 福清市| 吴桥县| 许昌县| 庆安县| 土默特左旗| 博湖县| 吴旗县| 焉耆| 南汇区| 景谷| 罗江县| 安福县| 综艺| 牟定县| 象州县| 拜泉县| 卢龙县| 毕节市| 莲花县| 泽普县|